Orlando, FL-Reports of the prophylactic properties of isoflavones and other natural substances on cancer cell lines are common, but few-if any-have demonstrated properties as potentially strong as those evidenced by a Japanese nutritional supplement containing a novel form of genistein.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.